Survival differences among AYAs with blood cancersJanuary 11, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLALLHodgkin LymphomaCMLNon-Hodgkin Lymphoma
Marine animals aid development of cytotoxicity assayJanuary 11, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLCMLNon-Hodgkin LymphomaAggressive Lymphomas
Overcoming resistance to ibrutinib in CLLJanuary 9, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
DLBCL survivors at greater risk of autoimmune, infectious diseasesJanuary 3, 2018Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Brentuximab vedotin sBLA receives priority reviewJanuary 3, 2018Lymphoma & Plasma Cell DisordersHodgkin LymphomaAggressive Lymphomas
Update reveals ongoing responses in ZUMA-1December 29, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Research explains why cisplatin causes hearing lossDecember 28, 2017Lymphoma & Plasma Cell DisordersMultiple MyelomaHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Chemo-free combo should be option for rel/ref CLL, doc saysDecember 22, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Risk stratification may be possible with JCAR017December 21, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Pembrolizumab sBLA receives priority reviewDecember 16, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Primary analysis confirms interim findings of CTL019 in DLBCLDecember 15, 2017Lymphoma & Plasma Cell DisordersAggressive Lymphomas
Technique may be effective for diagnosing NHLDecember 14, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Combo prolongs survival in lymphoma modelsDecember 1, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Inhibitor exhibits activity against range of lymphomasNovember 30, 2017Lymphoma & Plasma Cell DisordersHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
CCSs have increased risk of hypertensionNovember 24, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas